Evidence map›Paper›PMID 30801616›Full record

ArticleJAMA internal medicine2019

Association of Adolescent Hypertension With Future End-stage Renal Disease.

Adi Leiba, Boris Fishman, Gilad Twig, David Gilad, Estela Derazne, Ari Shamiss, Tamar Shohat, Ofir Ron, Ehud Grossman

Open access · bronzeAbstract readMulticenter Study
In one paragraph

Article in JAMA internal medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 1 pooled it
6.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 1 synthesis or guideline pooled it, 79 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. [Folic acid supplementation alleviates high-salt diet-induced renal fibrosis in mice].Nan fang yi ke da xue xue bao = Journal of Southern Medical University · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Expression of LRG-1 in mice with hypertensive renal damage and its significance.Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2023
    Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Frontiers in medicine · 2022
    Article
  18. Article
  19. Cumulative hypertension burden and risk of end-stage renal disease.Hypertension research : official journal of the Japanese Society of Hypertension · 2021
    Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Adi LeibaDivision of Nephrology and Hypertension, Assuta Ashdod Academic Medical Center, Ben Gurion University, Beer Sheva, Israel.
Boris FishmanIDF Medical Corps, Tel Hashomer, Ramat Gan, Israel.
Gilad TwigIDF Medical Corps, Tel Hashomer, Ramat Gan, Israel.
David GiladIDF Medical Corps, Tel Hashomer, Ramat Gan, Israel.
Estela DerazneSackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Ari ShamissAssuta Medical Center, Tel Aviv, Israel.
Tamar ShohatSackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Ofir RonIDF Medical Corps, Tel Hashomer, Ramat Gan, Israel.
Ehud GrossmanInternal Medicine D and Hypertension Unit, The Chaim Sheba Medical Center, Tel Hashomer, Israel.
Tel Aviv University · ILAssuta Medical Center · ILBen-Gurion University of the Negev · ILMount Auburn Hospital · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Importance: Hypertension is a leading risk factor of cardiovascular morbidity and mortality. The role of nonmalignant hypertension as the sole initiating factor of end-stage renal disease (ESRD) in non-African American populations has recently been questioned. Objective: To investigate the association between hypertension and future ESRD in otherwise healthy adolescents. Design, Setting, and Participants: This retrospective cohort study examined the data of 16- to 19-year-old healthy candidates for military service in the Israel Defense Forces between January 1, 1967, and December 31, 2013. Data were obtained from the central conscription registry of the Israel Defense Forces and the ESRD registry of the Israel Ministry of Health. Participants underwent a comprehensive medical assessment prior to their military service. Individuals with evidence of renal damage or kidney-related risk factors were excluded. The data analysis was conducted from February 12, 2017, to October 16, 2018. Main Outcomes and Measures: End-stage renal disease as recorded by the Israeli ESRD registry, including hemodialysis, peritoneal dialysis, renal transplant diagnosed between January 1, 1990, and December 31, 2014. Results: The cohort included 2 658 238 adolescents (1 596 709 [60.1%] male with a mean [SD] age of 17.4 [0.5] years), of whom 7997 (0.3%) had an established hypertension diagnosis. Half of the individuals in the hypertensive group were overweight (1559 [20.1%]) or obese (2243 [28.9%]), and most (7235 [90.5%]) were male. During a median follow-up of 19.6 years (52 287 945 person-years), 2189 individuals developed ESRD, with an incidence rate of 3.9 per 100 000 person-years. Adolescent hypertension was found to be associated with future ESRD (crude hazard ratio [HR], 5.07; 95% CI, 3.73-6.88). In a multivariable model adjusted for sex, age, years of education, body mass index, and other sociodemographic variables, the HR was 1.98 (95% CI, 1.42-2.77). When excluding participants with severe hypertension, the association with ESRD remained statistically significant (HR, 1.93; 95% CI, 1.37-2.70). In the subanalysis of nonoverweight adolescents, the association between hypertension and ESRD was statistically significant as well (HR, 2.11; 95% CI, 1.05-4.24). Conclusions and Relevance: Hypertension appears to be associated with a doubling of the risk of future ESRD in an otherwise healthy adolescent population.

Indexed as

RegistriesAdolescentBlood PressureDisease ProgressionFemaleHumansHypertensionIncidenceIsraelKidney Failure, ChronicMalePrognosisRenal DialysisRetrospective StudiesRisk AssessmentRisk Factors

Identifiers

PMID30801616
PMCPMC6450304
OpenAlexW2915146734

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.